Inversago Pharma
0 followers
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohe... Read more
Org chart
Michael D. Harvey
Chief Development Officer
Jean-Daniel Bélanger
VP, General Counsel & Secretary
Jianmin Duan
VP, Pharmacology & Pharmacokinetics
Karine Lalonde
VP, Clinical Operations
Jeremy Green
Head of Chemistry
Genevieve Gaucher
Vice President, Preclinical Development
Adriana Di Marco
Vice President CMC & Regulatory Affairs
Michèle Desjardins
Senior Director, Quality Assurance
Annie Chevrier
Office Administrator | Executive Assistant to the President & CEO
Micheline Beauvais
VP, Finance & Administration
